IntroductionThe burden of cancer-related mortality of common malignancies has been reported worldwide. However, whether bone cancer (BC), as a highly aggressive and heterogeneous group of rare cancers, followed a similar or distinct epidemiological pattern during such process remains largely unknown. We aimed to analyze the mortality and the temporal trends of BC in relation to gender, age, and premature death in Shanghai, China.MethodsWe conducted a population-based analysis of the mortality data of BC in Shanghai Pudong New Area (PNA) from 2005 to 2020. The epidemiological characteristics and long-term trends in crude mortality rates (CMRs), age-standardized mortality rates worldwide (ASMRWs), and rate of years of life lost (YLL) was analyzed using the Joinpoint regression program. The demographic and non-demographic factors affecting the mortality rate were evaluated by the decomposition method.ResultsThere are 519 BC-specific deaths accounting for 0.15% of all 336,823 deaths and 0.49% of cancer-specific death in PNA. The CMR and ASMRW of BC were 1.15/105 person-year and 0.61/105 person-year, respectively. The YLL due to premature death from BC was 6,539.39 years, with the age group of 60–69 years having the highest YLL of 1,440.79 years. The long-term trend of CMR, ASMRW, and YLL rate significantly decreased by −5.14%, −7.64%, and −7.27%, respectively, per year (all p < 0.05) in the past 16 years. However, the proportion of BC-specific death within the total cancer-specific death dropped to a plateau without further improvement since 2016, and a remarkable gender and age disparity was noticed in the observed reduction in mortality. Specifically, the elderly benefited less but accounted for a larger percentage of BC population in the last decades. Although the overall mortality of BC decreased, there was still a significant upward trend toward an increased mortality rate caused by the aging of the BC patients.ConclusionOur study provides novel insights on the epidemiological characteristics and longitudinal dynamics of BC in a fast urbanization and transitioning city. As a rare disease affecting all ages, the burden of BC among the elderly emerged to form an understudied and unmet medical need in an aging society.

ObjectiveLiver cancer is one of the most common causes of cancer-related death. Understanding how demographic factors influence mortality due to liver cancer is crucial for optimizing disease-control strategies. We aimed to characterize the long-term trends in the mortality and years of life lost (YLL) of liver cancer in Shanghai, China, 1973–2019, and quantitatively analyze the contributions of demographic and non-demographic factors on the mortality of liver cancer.MethodsUsing mortality data from the Mortality Registration System of Pudong New Area, the largest district of Shanghai with a population of permanent resident of 5.68 million, during 1973–2019, we analyzed the temporal trends for the mortality rates and YLL by Joinpoint Regression Program. The difference decomposition method was employed to estimate the increasing mortality rates related to demographic and non-demographic factors.ResultsA total of 21,530 deaths from liver cancer occurred from 1973 to 2019. The crude mortality rates (CMR) and age-standardized mortality rate by Segi's world standard population (ASMRW) of liver cancer were 26.73/105 person-years and 15.72/105 person-years, respectively. The CMR, ASMRW, and YLL rates of liver cancer showed significantly decreasing trends in males, females and the total population from 1973 to 2019, whereas the upward trends in the YLL were seen in males, females and the total population (all P < 0.05). A significant upward trend was observed in the increased CMR caused by demographic factors, but the changing rate caused by non-demographic factors decreased.ConclusionsThe CMR and ASMRW of liver cancer continually decreased although YLL increased during 1973–2019 in Pudong New Area, Shanghai. The demographic factors, especially aging, might be responsible for the increase in the mortality of liver cancer. More effective prevention strategies tailored to liver cancer are needed to further reduce its disease burden in the elderly population.

Booming China Assisted Living Market: Discover key trends, drivers, and challenges shaping this rapidly expanding sector, projected to reach (estimated) $XX million by 2025 with a CAGR exceeding 12%. Learn about leading companies and regional market shares in this comprehensive analysis. Recent developments include: In September 2021, the Grand Opening of Lendlease's landmark senior living project in Qingpu, Shanghai, was announced. Ardo Gardens provides a welcoming and well-being-focused environment for seniors to live vibrant and active lives, supported by luxury facilities and the best services., In May 2021, New China Life Insurance Co. Ltd opened a new elderly care community in Beijing's Yanqing district, totaling 280,000 sq. m and 2,000 apartments. The community will provide about 200 long-term apartments tailored for the elderly and 100 short-term guest rooms in the project's first phase, along with entertainment, catering, sports, medical care, social exchange, and wealth management services.. Notable trends are: Increase in Senior Population and Life Expectancy.

As of 2023, the bulk of the Chinese population was aged between 25 and 59 years, amounting to around half of the population. A breakdown of the population by broad age groups reveals that around 61.3 percent of the total population was in working age between 16 and 59 years in 2023. Age cohorts below 25 years were considerably smaller, although there was a slight growth trend in recent years. Population development in China Population development in China over the past decades has been strongly influenced by political and economic factors. After a time of high fertility rates during the Maoist regime, China introduced birth-control measures in the 1970s, including the so-called one-child policy. The fertility rate dropped accordingly from around six children per woman in the 1960s to below two at the end of the 20th century. At the same time, life expectancy increased consistently. In the face of a rapidly aging society, the government gradually lifted the one-child policy after 2012, finally arriving at a three-child policy in 2021. However, like in most other developed countries nowadays, people in China are reluctant to have more than one or two children due to high costs of living and education, as well as changed social norms and private values. China’s top-heavy age pyramid The above-mentioned developments are clearly reflected in the Chinese age pyramid. The age cohorts between 30 and 39 years are the last two larger age cohorts. The cohorts between 15 and 24, which now enter childbearing age, are decisively smaller, which will have a negative effect on the number of births in the coming decade. When looking at a gender distribution of the population pyramid, a considerable gender gap among the younger age cohorts becomes visible, leaving even less room for growth in birth figures.

In 2024, the mortality rate in Shanghai municipality ranged at approximately **** deaths per 1,000 inhabitants. The population of Shanghai is aging rapidly. This general trend has been mitigated by the constant inflow of migrants in past years.

Supplementary Material 1.

The In-Home Care & Other Household Services industry in China has not developed very well in the past few years. Due to the COVID-19 pandemic, many services provided by the industry cannot be implemented, resulting in a decrease in industry revenue. Industry revenue is expected to decrease at an annualized rate of 4.7% over the five years through 2024 to $7.1 billion. The continuous growth of China's population and the trend of aging have led to a great demand for industries in society, and currently the industry has not formed a good supply-demand relationship.Industry profit is expected to total 3.7% of revenue in 2024. Total wages are expected to decrease by an annualized 3.8% over the five years through 2024 to $3.2 billion. The technological barriers in the industry are low, resulting in a large workforce and low profits. The industry is typically labor-intensive, with wages accounting for 45.8% of industry revenue in 2024. There are large number of small-size companies and self-employed practitioners in the industry. Industry concentration is very low. The largest company in the industry represents only 0.3% of industry revenue in 2024. Most participants operate in local markets only, and just a small number of franchise chain companies are able to cover multiple regions.The industry is forecast to continue growing strongly in the next five years, benefiting from Chinese residents' upgrading consumption, the third-child policies implemented in 2022, and as China becomes an aging society. Industry revenue is expected to increase an annualized 1.5% over the five years through 2029 to total $7.6 billion. Market shares are expected to increase towards franchise chain companies, which are encouraged by the Government. The industry's concentration level will rise, but still stay low. Customers will likely prefer high-end services, due to their increasing purchasing power. Furthermore, O2O platforms are projected to become a major channel for both consumers and industry practitioners in the industry.

The global Medical Bed Head Unit market is experiencing steady growth, with a market size of $1245 million in 2025 and a projected Compound Annual Growth Rate (CAGR) of 4.1% from 2025 to 2033. This growth is driven by several factors, including the increasing aging population globally leading to a higher demand for advanced healthcare facilities and the rising prevalence of chronic diseases requiring extended hospital stays. Technological advancements in bed head units, such as the integration of smart features and improved patient monitoring capabilities, are further fueling market expansion. Furthermore, the growing focus on improving patient comfort and safety in healthcare settings is contributing to the adoption of sophisticated bed head units. Key players such as Shanghai Zhenghua Medical Equipment, Silbermann Technologies, and Dräger are shaping the market landscape through innovation and expansion strategies. However, the market faces certain restraints, primarily the high initial investment cost associated with advanced bed head units, which can be a barrier for smaller healthcare facilities. The market's growth is also influenced by factors such as stringent regulatory approvals and the potential for technological obsolescence. Despite these challenges, the long-term outlook for the Medical Bed Head Unit market remains positive, driven by continuous advancements in medical technology and the ongoing need for improved patient care. The market segmentation is likely diversified across unit type (basic, advanced, etc.), functionality (power, communication, monitoring), and end-user (hospitals, clinics, long-term care facilities). A detailed regional breakdown is not provided, but considering global trends, markets in North America, Europe, and Asia-Pacific would likely dominate market share.

Discover the booming anti-bedsore cushion market! Learn about its impressive CAGR, key drivers, regional trends, and leading companies. This comprehensive market analysis forecasts significant growth through 2033, providing valuable insights for investors and industry professionals.

ObjectivesIt is important to assess the burden of ovarian cancer related premature death so as to develop appropriate evidence-based care and improve women’s health. This study aimed to characterize the long-term trends in mortality, survival and disease burden of ovarian cancer in Shanghai, China.Materials and MethodsCo-morbidities, crude mortality rate (CMR), age-standardised mortality rate by Segi’s world standard population (ASMRW), years of life lost (YLL), and survival rates were analysed. Temporal trends for the mortality rates and disease burden were analyzed using the Joinpoint Regression Program. Mortality rate increases by demographic and non-demographic factors were estimated by the decomposition method.ResultsA total of 1088 ovarian cancer as underlying cause of deaths were recorded. CMR and ASMRW were 4.82/105 and 2.32/105 person-years, respectively. The YLL was 16372.96 years, and the YLL rate was 72.46/105 person-years. The YLL rate increased only in the age group of 70-79 years (P = 0.017). The survival rates of ovarian cancer patients did not improve during the ten year period (2005-2015). The top co-morbidities were diseases of the respiratory system, digestive system, and circulatory system. The rates of ovarian cancer deaths caused by non-demographic and demographic factors increased by 21.29% (95%CI: 4.01% to 41.44%, P = 0.018) and 25.23% (95%CI: 14.64% to 36.81%, P < 0.001), respectively.ConclusionsPopulation ageing and all cause of death may affect ovarian cancer related deaths in Pudong, Shanghai. The high mortality and the stagnant survival rates suggest the need for more efforts in targeted prevention and treatment of this disease.

Explore the burgeoning Creatine market for healthcare products, driven by health benefits and a growing aging population. Discover market size, CAGR, key drivers, and regional insights for informed decisions.

Discover the booming nursing car market! This comprehensive analysis reveals a $250 million market in 2025, projected to grow at a 7% CAGR through 2033. Explore market trends, segmentation (electric vs. manual, hospital vs. clinic), key players, and regional insights for North America, Europe, and Asia-Pacific. Learn how technological advancements and aging populations drive this dynamic sector.

Discover the booming PVC Enteral Nutrition Infusion Set market! This comprehensive analysis reveals a CAGR of 7%, reaching $2.7B by 2033, driven by aging populations and chronic disease prevalence. Explore regional breakdowns, key players (BQ+ Medical, Medwin France, etc.), and future trends impacting this dynamic sector.

The global PVC Enteral Nutrition Infusion Set market is projected to reach $800 million by 2033, growing at a CAGR of 7%. Explore market drivers, restraints, key players (BQ+ Medical, Medwin France, Cathwide Medical), and regional trends in this detailed analysis.